Mark W Perry's Net Worth

$710 Million

Estimate Recalculated Feb 22, 2024 05:30PM EST

Who is Mark W Perry?

Mark W Perry has an estimated net worth of $710 Million. This is based on reported shares across multiple companies, which include Workday, Inc., PHARMOS CORP, Echo Global Logistics, Inc., Financial Engines, Inc., FUSION-IO, INC., GLU MOBILE INC, INNERWORKINGS INC, HYPERION THERAPEUTICS INC, SUPERNUS PHARMACEUTICALS INC, ZHONE TECHNOLOGIES INC, Groupon, Inc., AMICUS THERAPEUTICS INC, VONAGE HOLDINGS CORP, TARGACEPT INC, SUNESIS PHARMACEUTICALS INC, Transcept Pharmaceuticals Inc, MOTRICITY INC, TIVO INC, Neutral Tandem Inc, SOURCEFIRE INC, BOINGO WIRELESS INC, AUDIENCE INC, ARADIGM CORP, INHIBITEX, INC., PEPLIN INC, HEMOSENSE INC, ARYx Therapeutics, Inc., Data Domain, Inc., INTERCELL USA, INC., INTARCIA THERAPEUTICS, INC, FOXHOLLOW TECHNOLOGIES, INC., PHARMION CORP, MYOGEN INC, MAGMA DESIGN AUTOMATION INC, ZTI MERGER SUBSIDIARY III INC, APPLIED IMAGING CORP, and OCCAM NETWORKS INC/DE.

SEC CIK

Mark W Perry's CIK is 0001062466

Past Insider Trading and Trends

2007 was Mark W Perry's most active year for acquiring shares with 126 total transactions. Mark W Perry's most active month to acquire stocks was the month of February. 2012 was Mark W Perry's most active year for disposing of shares, totalling 53 transactions. Mark W Perry's most active month to dispose stocks was the month of February. 2003 saw Mark W Perry paying a total of $47,231,167.68 for 13,514,957 shares, this is the most they've acquired in one year. In 2012 Mark W Perry cashed out on 67,431,861 shares for a total of $269,758,539.94, their largest year based on trade value.

Attention insiders: Dive deeper into market movements and stay ahead of the curve with Benzinga Pro! From up-to-the-second news to audio squawks and interactive data tools, it's everything you need to supercharge your trading strategy. Experience the Benzinga Pro advantage today and transform the way you trade with our exclusive free trial!

GLU MOBILE INC No price found

Investor

Form Type
Δ Own
Qty.
Price
Size ($)
Own
Filing Date
Type
Is Scheduled
Trade Dates
Form 4
+6.76%
375K
$1.50
$562,500.00
5.92M
Aug 8
Form 4
+15.64%
750K
$1.00
$750,000.00
5.54M
Aug 27
Form 4
+1.11%
52.7K
$1.92
$101,185.92
4.79M
Mar 3
Form 4
4.74M
4.74M
Mar 27
Form 3
0
0
No matching records found

SUNESIS PHARMACEUTICALS INC (VIRX) Snapshot price: $0.586

Investor

Form Type
Δ Own
Qty.
Price
Size ($)
Own
Filing Date
Type
Is Scheduled
Trade Dates
Form 4
33.82M
$0.28
33.82M
Jun 30
Form 4
0
0
Oct 30
Form 3
0
0
No matching records found

MOTRICITY INC No price found

Investor

Form Type
Δ Own
Qty.
Price
Size ($)
Own
Filing Date
Type
Is Scheduled
Trade Dates
Form 3/A
0
0
Form 3
0
0
No matching records found

Neutral Tandem Inc No price found

Investor

Form Type
Δ Own
Qty.
Price
Size ($)
Own
Filing Date
Type
Is Scheduled
Trade Dates
Form 3
0
0
No matching records found

SOURCEFIRE INC No price found

Investor

Form Type
Δ Own
Qty.
Price
Size ($)
Own
Filing Date
Type
Is Scheduled
Trade Dates
Form 4
-17.71%
-476.80K
$11.78
-$5,617,431.54
2.22M
May 6
Form 4
-16.13%
-517.75K
$12.06
-$6,242,889.78
2.69M
May 1 - May 4
Form 4
3.21M
3.21M
Mar 14
Form 3
0
0
No matching records found